Literature DB >> 18682292

Prediction of individual genetic risk of complex disease.

Naomi R Wray1, Michael E Goddard, Peter M Visscher.   

Abstract

Most common diseases are caused by multiple genetic and environmental factors. In the last 2 years, genome-wide association studies (GWAS) have identified polymorphisms that are associated with risk to common disease, but the effect of any one risk allele is typically small. By combining information from many risk variants, will it be possible to predict accurately each individual person's genetic risk for a disease? In this review we consider the lessons from GWAS and the implications for genetic risk prediction to common disease. We conclude that with larger GWAS sample sizes or by combining studies, accurate prediction of genetic risk will be possible, even if the causal mutations or the mechanisms by which they affect susceptibility are unknown.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682292     DOI: 10.1016/j.gde.2008.07.006

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  77 in total

1.  Meta-analysis of genetic association studies under heterogeneity.

Authors:  Binod Neupane; Mark Loeb; Sonia S Anand; Joseph Beyene
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

Review 2.  Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans: Genomic Prediction.

Authors:  Naomi R Wray; Kathryn E Kemper; Benjamin J Hayes; Michael E Goddard; Peter M Visscher
Journal:  Genetics       Date:  2019-04       Impact factor: 4.562

Review 3.  Statistical analysis of genetic interactions.

Authors:  Nengjun Yi
Journal:  Genet Res (Camb)       Date:  2010-12       Impact factor: 1.588

Review 4.  Bringing genome-wide association findings into clinical use.

Authors:  Teri A Manolio
Journal:  Nat Rev Genet       Date:  2013-07-09       Impact factor: 53.242

5.  Estimation of absolute risk for prostate cancer using genetic markers and family history.

Authors:  Jianfeng Xu; Jielin Sun; A Karim Kader; Sara Lindström; Fredrik Wiklund; Fang-Chi Hsu; Jan-Erik Johansson; S Lilly Zheng; Gilles Thomas; Richard B Hayes; Peter Kraft; David J Hunter; Stephen J Chanock; William B Isaacs; Henrik Grönberg
Journal:  Prostate       Date:  2009-10-01       Impact factor: 4.104

Review 6.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

Review 7.  Polygenic susceptibility to breast cancer: current state-of-the-art.

Authors:  Maya Ghoussaini; Paul D P Pharoah
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

8.  Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases.

Authors:  Hariklia Eleftherohorinou; Victoria Wright; Clive Hoggart; Anna-Liisa Hartikainen; Marjo-Riitta Jarvelin; David Balding; Lachlan Coin; Michael Levin
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

9.  How many genetic variants remain to be discovered?

Authors:  Yudi Pawitan; Ku Chee Seng; Patrik K E Magnusson
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

10.  Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information.

Authors:  Yonqing Zhang; Supriyo De; John R Garner; Kirstin Smith; S Alex Wang; Kevin G Becker
Journal:  BMC Med Genomics       Date:  2010-01-21       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.